TickerFacts.

Tvardi Therapeutics, Inc. (TVRD): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-12, first reflected in a filing dated 2025-03-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

7.78M
Year ended 2025-12-31
50.72M2012-12-31: 3.30M2013-12-31: 4.13M2014-12-31: 20.97M2015-12-31: 24.62M2016-12-31: 27.28M2017-12-31: 31.20M2018-12-31: 35.89M2019-12-31: 42.67M2020-12-31: 47.92M2021-12-31: 50.72M2022-12-31: 4.47M2023-12-31: 4.51M2024-12-31: 2.57M2025-12-31: 7.78M7.78M
2012-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-317.78M+202.3%2026-03-31, From 2025-01-01
2024-12-312.57Mn/c2026-03-31, From 2024-01-01
2023-12-314.51M+0.9%2025-03-11, From 2023-01-01
2022-12-314.47Mn/c2025-03-11, From 2022-01-01
2021-12-3150.72M+5.9%2024-03-06, From 2021-01-01
2020-12-3147.92M+12.3%2023-03-06, From 2020-01-01
2019-12-3142.67M+18.9%2022-03-01, From 2019-01-01
2018-12-3135.89M+15.0%2021-02-25, From 2018-01-01
2017-12-3131.20M+14.4%2020-02-27, From 2017-01-01
2016-12-3127.28M+10.8%2019-03-12, From 2016-01-01
2015-12-3124.62M+17.4%2018-03-15, From 2015-01-01
2014-12-3120.97Mn/c2017-03-10, From 2014-01-01
2013-12-314.13M+25.2%2016-03-11, From 2013-01-01
2012-12-313.30Mn/a2015-03-27, From 2012-01-01